Related Experiment Video

Updated: Oct 20, 2025

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence
08:07

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence

Published on: April 28, 2023

1.7K

Therapeutic Targeting of Autophagy in Pancreatic Cancer

Mona Foth1, Ignacio Garrido-Laguna2, Conan G Kinsey2

  • 1Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA.

Surgical Oncology Clinics of North America
|September 13, 2021
PubMed

Insights

This review explores inhibiting autophagy, a cellular process, as a potential pancreatic cancer therapy. It covers the role of autophagy in pancreatic cancer and emerging treatments.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Therapeutics

Background:

  • Autophagy is a cellular degradation process crucial for maintaining cellular homeostasis.
  • Dysregulation of autophagy is implicated in the development and progression of various cancers, including pancreatic cancer.
  • Targeting autophagy presents a promising therapeutic strategy in oncology.

Purpose of the Study:

  • To review the therapeutic potential of inhibiting autophagy in pancreatic cancer.
  • To discuss the role and significance of autophagy in pancreatic cancer.
  • To highlight current and emerging agents targeting autophagy for pancreatic cancer treatment.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of the autophagic process in the context of pancreatic cancer.
  • Examination of clinical trial data for autophagy inhibitors.

Main Results:

  • Autophagy plays a complex, often pro-tumorigenic role in pancreatic cancer.
  • Several agents targeting autophagy are in preclinical and clinical development.
  • Inhibition of autophagy demonstrates therapeutic promise in preclinical models of pancreatic cancer.

Conclusions:

  • Inhibiting autophagy represents a viable therapeutic strategy for pancreatic cancer.
  • Further clinical investigation of autophagy inhibitors is warranted.
  • Combination therapies involving autophagy inhibition may enhance treatment efficacy.
Keywords:
AutophagyAutophagy clinical trialsPancreatic cancerPancreatic cancer clinical trialsTherapeutics

More Related Videos

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.1K
Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy09:59

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy

Published on: May 3, 2013

18.1K

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K